Personalized, Online Help for Prescription Painkiller and Heroin Dependence: Confidential Treatment in a Doctor's Private Office

Wednesday, September 19, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

RICHMOND, Va., Sept. 18 Reckitt Benckiser PharmaceuticalsInc. announces an extensive new online resource that provides personalizedsupport and information to individuals who are dependent on prescriptionopioid painkillers and heroin. By helping dependent people find a path totreatment in a confidential and private setting, this unique online resourcesupports the overall goals of September as National Alcohol and Drug AddictionRecovery Month. While visiting, people seeking help for theirdependence and their families can register to receive information and supportthat is appropriate to their own personal needs.

Opioid dependence is a national health crisis that affects some sixmillion Americans from all walks of life, socioeconomic levels, ages andgenders. The World Health Organization (WHO) and the National Institute onDrug Abuse (NIDA) define opioid addiction as a long-term brain disease with abehavioral component. It is a treatable medical condition that is caused bychanges in the chemistry of the brain. This dependence can start with use ofmedicine that a doctor prescribes for pain but that a person continues to useafter the medical need for pain relief has passed. Or it may begin asrecreational drug use that spins out of control. is an important resource for opioid-dependent individualsand their families, including:

" is a terrific resource that I encourage all my opioid-dependent patients to use," said Michael Schiesser, MD, of Creekside Centerfor Integrative Medicine in Bellevue, WA. "As a physician, I am responsiblefor ensuring that my patients receive the best possible care, and thecustomized information offered to them through this Web site can go a long waytowards helping them remain in long-term recovery. The patient (and family)education offered by this resource is a valuable adjunct to the medicaltreatment I provide."

Among the information presented on, Suboxone(R)(buprenorphine HCl/naloxone HCl dihydrate) C-III Sublingual Tablets isfeatured as a medical treatment. Buprenorphine is the only FDA-approvedcontrolled medicine used to treat opioid dependence that can be prescribed bydoctors in their offices and with take-home prescriptions, under speciallegislation.

"The flexible and customized assistance provided by TurntoHelp.comexemplifies our longstanding commitment to patients, and we are proud tointroduce it during National Alcohol and Drug Addiction Recovery Month," saidShaun Thaxter, president of Reckitt Benckiser Pharmaceuticals Inc., marketersof Suboxone(R). "The site can now help people throughout the entire recoveryprocess, from recognizing the untreated disease to establishing long-termrecovery. Through 'Here to Help,' the Website guides users on entering arecovery plan and finding a doctor certified to treat with buprenorphine, aswell as providing full and accurate information about the disease state,useful outside resources and much more. Additionally, because we recognizethe significant role that family and friends play in substance abuse treatmentand recovery, portions of are specifically designed for them."

About Suboxone(R) Treatment for Opioid Dependence

After opioid-dependent patients are initially inducted onto Suboxone(R),the medicine may be prescribed in an office-based setting by certified doctorswith take-home prescriptions. This treatment modality is attractive to manypatients because of the privacy and convenience that office-based treatmentoffers. Buprenorphine is a partial opioid agonist, which allows it to be usedto treat opioid dependence for two critical reasons: first, it acts on thebrain to reduce cravings and withdrawal symptoms; and second, because it is apartial opioid agonist, it does not excite the same level of opioid-inducedbrain activity as full agonists do, and thus does not p

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store